文献速递乳房整形与再造创面修复

解读乳房切除术后SKIN评分:其在即刻乳房再造中预测性能的评估

Decoding the Mastectomy SKIN Score: An Evaluation of Its Predictive Performance in Immediate Breast Reconstruction.
PubMed 文献 · Plast Reconstr Surg · 2023-06-07

该回顾性队列研究纳入2001年1月至2021年1月间乳房切除术后即刻乳房再造后发生乳房切除皮瓣坏死(MSFN)的连续患者,评估SKIN复合评分与长期结局的关联。结果显示SKIN复合评分对再次手术预测能力差(曲线下面积0.56),各评分组间手术室清创、30天再入院、任何并发症及因并发症再次手术率均无显著差异。

要点

  • SKIN复合评分对MSFN术后再次手术预测能力差,曲线下面积0.56。
  • 不同SKIN复合评分组间手术室清创、30天再入院、任何并发症及因并发症再次手术率均无显著差异。
  • 植入物再造亚组分析中,不同SKIN复合评分组间上述结局亦无显著差异。

核心结论

  • SKIN评分对MSFN术后结局和再次手术的预测能力差。
  • 需要一种结合乳房解剖外观、影像数据和患者层面危险因素的个体化风险评估工具。

研究设计与样本

  • 回顾性队列研究,纳入2001年1月至2021年1月期间乳房切除术后即刻乳房再造后发生MSFN的连续患者,共273例患者299次再造,平均随访111.8±3.9个月。

主要发现

  • 大多数患者SKIN复合评分为B2(25.0%,n=13),其次为D2(17.3%)和C2(15.4%)。
  • 基于SKIN复合评分,手术室清创率(P=0.347)、30天再入院率(P=0.167)、任何并发症发生率(P=0.492)及因并发症再次手术率(P=0.189)均无显著差异。
  • SKIN复合评分对再次手术预测能力差,曲线下面积为0.56。
  • 植入物再造亚组分析显示,基于SKIN复合评分,手术室清创率(P=0.986)、30天再入院率(P=0.530)、任何并发症发生率(P=0.492)及因并发症再次手术率(P=0.655)均无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The skin ischemia and necrosis (SKIN) score was introduced to standardize the assessment of mastectomy skin flap necrosis (MSFN) severity and the need for reoperation. The authors evaluated the association between the SKIN score and the long-term postoperative outcomes of MSFN after mastectomy and immediate breast reconstruction. METHODS: The authors conducted a retrospective cohort study of consecutive patients who developed MSFN after mastectomy and immediate breast reconstruction from January of 2001 to January of 2021. The primary outcome was breast-related complications after MSFN. Secondary outcomes were 30-day readmission, operating room (OR) débridement, and reoperation. Study outcomes were correlated with the SKIN composite score. RESULTS: The authors identified 299 reconstructions in 273 consecutive patients with mean follow-up time of 111.8 ± 3.9 months. Most patients had a composite SKIN score of B2 (25.0%, n = 13), followed by D2 (17.3%) and C2 (15.4%). We found no significant difference in rates of OR débridement ( P = 0.347), 30-day readmission ( P = 0.167), any complication ( P = 0.492), or reoperation for a complication ( P = 0.189) based on the SKIN composite score. The composite skin score was a poor predictor of reoperation, with an area under the curve of 0.56. A subgroup analysis in patients who underwent implant-based reconstruction revealed no difference in rates of OR débridement ( P = 0.986), 30-day readmission ( P = 0.530), any complication ( P = 0.492), or reoperation for a complication ( P = 0.655) based on the SKIN composite score. CONCLUSIONS: The SKIN score was a poor predictor for postoperative MSFN outcomes and reoperation. An individualized risk-assessment tool that incorporates the anatomic appearance of the breast, imaging data, and patient-level risk factors is needed. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, IV.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Hassan AM, Nguyen HT, Elias AM, et al. Decoding the Mastectomy SKIN Score: An Evaluation of Its Predictive Performance in Immediate Breast Reconstruction. Plast Reconstr Surg. 2023. PMID: 37289944. doi:10.1097/PRS.0000000000010817

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。